| 0 |
Programmed Death Receptor-1 Blocking Antibody [EPC] |
36 |
0.0004 |
| 1 |
CTLA-4-directed Blocking Antibody [EPC] |
10 |
0.0002 |
| 2 |
Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
3 |
0.0001 |
| 3 |
Thrombopoietin Receptor Agonist [EPC] |
2 |
0.0001 |
| 4 |
CD19-directed Chimeric Antigen Receptor [EPC] |
1 |
0.0001 |
| 5 |
Programmed Death Ligand-1 Blocker [EPC] |
2 |
0.0001 |
| 6 |
Alkylating Drug [EPC] |
12 |
0.0000 |
| 7 |
BCL-2 Inhibitor [EPC] |
3 |
0.0000 |
| 8 |
Poly(ADP-Ribose) Polymerase Inhibitor [EPC] |
1 |
0.0000 |
| 9 |
Calcineurin Inhibitor Immunosuppressant [EPC] |
6 |
0.0000 |
| 10 |
Platinum-based Drug [EPC] |
12 |
0.0000 |
| 11 |
Insulin [EPC] |
2 |
0.0000 |
| 12 |
Typical Antipsychotic [EPC] |
1 |
0.0000 |
| 13 |
Microtubule Inhibitor [EPC] |
5 |
0.0000 |
| 14 |
Penem Antibacterial [EPC] |
1 |
0.0000 |
| 15 |
Topoisomerase Inhibitor [EPC] |
2 |
0.0000 |
| 16 |
Central alpha-2 Adrenergic Agonist [EPC] |
1 |
0.0000 |
| 17 |
Nucleoside Metabolic Inhibitor [EPC] |
5 |
0.0000 |
| 18 |
Complement Inhibitor [EPC] |
1 |
0.0000 |
| 19 |
CD20-directed Cytolytic Antibody [EPC] |
3 |
0.0000 |
| 20 |
Histamine-2 Receptor Antagonist [EPC] |
1 |
0.0000 |
| 21 |
Atypical Antipsychotic [EPC] |
3 |
0.0000 |
| 22 |
Vascular Endothelial Growth Factor Inhibitor [EPC] |
1 |
0.0000 |
| 23 |
Corticosteroid [EPC] |
6 |
0.0000 |
| 24 |
Mood Stabilizer [EPC] |
1 |
0.0000 |
| 25 |
Anti-epileptic Agent [EPC] |
1 |
0.0000 |
| 26 |
Osmotic Laxative [EPC] |
1 |
0.0000 |
| 27 |
beta-Adrenergic Blocker [EPC] |
1 |
0.0000 |
| 28 |
Platelet Aggregation Inhibitor [EPC] |
1 |
0.0000 |
| 29 |
Proton Pump Inhibitor [EPC] |
1 |
0.0000 |
| 30 |
Nonsteroidal Anti-inflammatory Drug [EPC] |
1 |
0.0000 |